Trial intelligence / Profile preview

Mumps Live Attenuated Vaccine in 8–12 Month Infants

CTR20200383Phase 4Completed

Sponsor
Sinovac Biotech Ltd.
Start
Jun 2020
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of mumps vaccine, live in mumps, sponsored by Sinovac Biotech Ltd.. Started Jun 2020; status: completed.

02

Drugs

mumps vaccine, live
03

Conditions

mumps

Beyond the preview

Go deeper on CTR20200383.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20200383.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call